Building Your First AI Sales Agent: From Concept to Deployment in Pharma
Opening
The pharmaceutical industry is witnessing a significant surge in the adoption of artificial intelligence (AI), with 65% of organizations regularly using generative AI, nearly double from 10 months prior according to Articsledge. This trend is expected to continue, with the AI market projected to grow from $57.99 billion in 2025 to $240.58 billion by 2030, at an annual growth rate of 32.9% according to Articsledge. As AI transforms the pharmaceutical landscape, sales professionals must adapt to stay ahead. This article provides a comprehensive guide on building an AI sales agent, covering tool selection, API integrations, compliance guardrails, and deployment strategies. By the end of this article, readers will be equipped to design and deploy their own AI sales agent, leveraging the power of AI to drive sales growth and improve customer engagement.
The Current State
The pharmaceutical industry is undergoing a significant transformation, driven by the increasing adoption of AI. 78% of organizations now use AI, and this number is expected to continue growing according to Articsledge. Companies like Novartis, Astellas Pharma Inc., and Pfizer are already leveraging AI to enhance their commercial operations, drug discovery capabilities, and research and development (R&D) pipelines. For instance, Novartis's VP of AI and Innovation, Scott Bradley, discusses the company's focus on AI in pharmaceutical commercial operations on The AI in Business Podcast. Astellas Pharma Inc. uses AI technology to enhance its drug discovery capabilities, as outlined in its Integrated Report 2025 available on the company's website. Pfizer has the largest R&D pipeline, with over 270 drugs in its development portfolio, as reported by Statista on its website.
The use of AI in pharmaceutical sales is also becoming more prevalent, with 314 million AI tool users globally in 2024, projected to reach 378 million by 2025 according to GGC. The global sales intelligence market is expected to reach $9.02 billion by 2034 according to Superagi. As AI adoption continues to grow, pharmaceutical sales professionals must develop the skills and knowledge needed to effectively leverage AI in their daily work. This includes understanding how to build and deploy AI sales agents, which can help automate tasks, analyze data, and provide personalized customer experiences.
The integration of AI in pharmaceutical sales is not limited to large companies. Small and medium-sized enterprises (SMEs) can also benefit from AI-powered sales agents, which can help them compete with larger companies and improve their sales performance. According to Sparkco.ai, AI can help pharmaceutical companies achieve $28 billion in annual cost savings in drug development by 2025. This highlights the significant potential of AI to transform the pharmaceutical industry and improve sales performance.
The Challenge
Despite the growing adoption of AI, many pharmaceutical companies struggle to move beyond pilots to scaled implementation, delivering measurable business impact. Many organizations struggle to move beyond pilots to scaled implementation according to the Digital Health Coalition. This is often due to the lack of clear strategies, inadequate data infrastructure, and insufficient talent. Additionally, the pharmaceutical industry is heavily regulated, and AI sales agents must comply with various laws and regulations, such as data protection and privacy laws.
The challenge of implementing AI in pharmaceutical sales is further complicated by the need for compliance guardrails, which ensure that AI systems operate within established boundaries and guidelines. This requires careful planning, monitoring, and maintenance to prevent errors, biases, and non-compliance. Furthermore, the lack of standardization in AI technologies and the rapid evolution of AI capabilities can make it difficult for pharmaceutical companies to keep pace with the latest developments.
To overcome these challenges, pharmaceutical companies must develop a deep understanding of AI technologies, their applications, and their limitations. They must also invest in data infrastructure, including data storage, processing, and analytics capabilities, to support AI adoption. Moreover, they must develop talent with the necessary skills to design, deploy, and maintain AI systems. According to Articsledge, 30% of AI leaders report CEO satisfaction with investment returns, despite an average spending of $1.9 million. This highlights the need for careful planning and execution to ensure that AI investments deliver measurable business impact.
What's Working
Despite the challenges, many pharmaceutical companies are achieving success with AI-powered sales agents. These companies are leveraging AI to automate tasks, such as data analysis, customer segmentation, and lead generation, freeing up sales representatives to focus on high-value activities like customer engagement and relationship-building. AI is also helping pharmaceutical companies to analyze large datasets, identify patterns, and gain insights that inform sales strategies and tactics.
Companies like Novartis and Astellas Pharma Inc. are using AI to enhance customer experiences, providing personalized interactions, and improving customer satisfaction. Pfizer is leveraging AI to optimize its R&D pipeline, identifying potential drug candidates, and streamlining the development process. These companies are achieving significant benefits from AI adoption, including improved sales performance, increased efficiency, and enhanced customer experiences.
To achieve similar success, pharmaceutical companies must develop a clear AI strategy, aligned with their business goals and objectives. They must also invest in AI talent, including data scientists, AI engineers, and sales professionals with AI skills. Furthermore, they must establish compliance guardrails, ensuring that AI systems operate within established boundaries and guidelines. By following these best practices, pharmaceutical companies can unlock the full potential of AI-powered sales agents and drive business growth.
The Road Ahead
As AI continues to evolve, pharmaceutical companies can expect significant advancements in AI capabilities, including improved natural language processing, enhanced computer vision, and increased explainability. These advancements will enable pharmaceutical companies to develop more sophisticated AI sales agents, capable of analyzing complex data, identifying patterns, and providing personalized customer experiences.
The future of AI in pharmaceutical sales will also be shaped by emerging technologies, such as blockchain, the Internet of Things (IoT), and 5G networks. These technologies will enable pharmaceutical companies to develop more secure, transparent, and connected AI systems, capable of analyzing vast amounts of data in real-time. As AI adoption continues to grow, pharmaceutical companies must stay ahead of the curve, investing in AI research and development, and developing the talent and infrastructure needed to support AI-powered sales agents.
Action Items
To get started with building an AI sales agent, pharmaceutical sales professionals and marketing managers should consider the following key insights:
* Develop a clear AI strategy, aligned with business goals and objectives
* Invest in AI talent, including data scientists, AI engineers, and sales professionals with AI skills
* Establish compliance guardrails, ensuring that AI systems operate within established boundaries and guidelines
* Leverage AI to automate tasks, analyze large datasets, and provide personalized customer experiences
* Stay up-to-date with the latest AI advancements and emerging technologies, including blockchain, IoT, and 5G networks
To take the next steps, readers can:
1. Conduct an AI readiness assessment, evaluating their organization's AI capabilities and identifying areas for improvement
2. Develop an AI strategy, outlining clear goals, objectives, and timelines for AI adoption
3. Invest in AI talent, including hiring data scientists, AI engineers, and sales professionals with AI skills, or providing training and development programs for existing staff